Institut de veille sanitaire

About: Institut de veille sanitaire is a healthcare organization based out in Saint-Maurice, France. It is known for research contribution in the topics: Population & Public health. The organization has 1055 authors who have published 1547 publications receiving 56945 citations. The organization is also known as: INVS & InVS.

Deaths from chronic obstructive pulmonary disease in France, 1979–2002: a multiple cause analysis

Abstract: Background: A study was undertaken of deaths with an underlying or associated cause of chronic obstructive pulmonary disease (COPD), and trends in COPD mortality from 1979 to 2002 in France were analysed. Methods: Data were obtained from the Centre of Epidemiology on the Medical Causes of Death (CepiDc) for individuals aged 45 years and over. Owing to implementation of ICD-10 in 2000 for recording causes of death, two separate periods were analysed (1979–99 and 2000–2). Results: In 2000–2, COPD was the underlying cause of 1.4% of deaths (deaths from COPD) and was mentioned on the death certificate in 3.0% (deaths with COPD). The other main underlying causes in these cases were cardiovascular diseases (32.0%) and cancers (24.5%). In 1979–99, age standardised rates of death with COPD remained stable in men (−0.01%/year) and increased in women (+1.7%/year). The mean annual rates of death with COPD per 100 000 were 84 for men and 19 for women in 2000–2. Conclusion: Multiple cause analysis improved the estimate of COPD related mortality. In 1979–99, COPD related mortality rates in France were stable in men but increased in women. Implementation of ICD-10 in 2000 introduced substantial discontinuities in mortality trends.

Two consecutive large outbreaks of Salmonella enterica serotype Agona infections in infants linked to the consumption of powdered infant formula.

Abstract: Background:An increase of isolation of Salmonella Agona was observed in January through February 2005 among infants in France.Methods:Case–control study, food trace-back and microbiologic investigations were promptly carried out.Results:A total of 141 confirmed cases <12 months of age were identifie

Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).

Abstract: Monitoring trends in residual risk of transfusion-transmitted viral infections is important to assess improvements in blood safety and to adapt the risk reduction policies. These trends were analysed in France over 4 periods of 3 years (1992-1994, 1995-1997, 1998-2000 and 2001-2003). The 2001-2003 estimates were compared to the results of HIV-1 and HCV NAT implemented on all blood donations in July 2001. Due to improvements in donor recruitment and selection, continuing progress in screening assays, and preventive measures taken in the community to control infections, a significant decrease was observed in residual risks for HIV, HCV and HBV between 1992 and 2003. The residual risk is currently extremely low: for the 2001-2003 period, this risk was estimated at 1 in 3.15 million donations for HIV, at 1 in 10 million for HCV and at 1 in 640 000 for HBV. Of the 6.14 million donations screened with NAT between July 2001 and December 2003 in France, 2 HIV-positive and 3 HCV-positive donations were discarded thanks to NAT, representing a yield of 1 in 3.07 million for HIV and 1 in 2.05 million for HCV. These results show the limited benefit of NAT and suggest that its cost-effectiveness is poor.

Patterns of hypertension management in France (ENNS 2006–2007)

Abstract: Objectives: The objectives of this study were to describe the hypertensive population and therapeutic management of hypertension in subjects between 18 and 74 years of age in continental France in 2006.Methods: ENNS was a cross-sectional survey conducted in continental France in 2006–2007. Blood pressure (BP) was measured in a national sample of non-institutionalized adults aged 18–74 years and pharmacological treatment was collected by a self-questionnaire. Hypertension was defined by systolic blood pressure (SBP) ≥140 mmHg, diastolic blood pressure (DBP) ≥90 mmHg, or treatment with BP-lowering drugs. The therapeutic control of treated hypertensive patients was defined by SBP <140 mmHg and DBP <90 mmHg.Results: The prevalence of hypertension was 31.0%. Half of hypertensive subjects reported taking an antihypertensive drug (50.3%) and nearly half of them were treated with a single antihypertensive pharmacological class (44.3%). Overall, among hypertensives, 25.6% had a satisfactory BP control.Conclusions:...